Print

RV 144

A Phase III Trial of Sanofi Pasteur Live Recombinant ALVAC-HIV (vCP1521) Priming With VaxGen gp120 B/E (AIDSVAX B/E) Boosting in HIV-Uninfected Thai Adults

Trial Details:

III Completed
DoD, Thailand MOPH, NIAID, TAVEG, Sanofi, VaxGen October 02, 2003
ALVAC-HIV vCP1521,AIDSVAX gp120 B/E
ALVAC-HIV vCP1521 Viral Vector - Pox
AIDSVAX gp120 B/E Protein
Thailand 16,403
http://www.hivresearch.org/home.php